|
DVSSciences
Inc. is an analytical equipment and
reagents
development company that produce and market globally the CyTOF™,
a high throughput mass cytometer for individual cell
analysis based on a novel elemental mass-spectrometry detection
technology, and the MAXPAR™
system of novel reagents related
to massively multi-parametric biological assays.
IAS
Inc.
was established in
2004 and the principals of IAS Inc. have more than 70 years of combined
experience in the ICP-MS technology. Two of the principals worked with
the researchers of DVS Sciences while they worked at PerkinElmer Sciex
in Toronto. IAS Inc. is especially well known in the semiconductor
market in Asia Pacific region as well as Japan and now expands into the
cytometry market.
Mass
Cytometry is a technology
that addresses applications that are typically run by flow cytometer
analyzers, but extends the capability to many simultaneous parameters.
The detection technology is based on atomic mass spectrometry (the
state of the art technology for the determination of the elemental
composition of materials, but heretofore foreign to biologists). Hence,
it offers the specificity, dynamic range and quantitative capability of
mass spectrometry in a format that is familiar to flow cytometry
practitioners.
|
